Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Reinforcing commitment to ethical and sustainable growth
Subscribe To Our Newsletter & Stay Updated